Fig. 2From: Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort studyThe evolution of mean body weight, body mass index, and skeletal muscle index during follow-up in the whole study population (n = 115)Back to article page